Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European…

By H. Brunner, J. Cockcroft, J. Deanfield, A. Donald, E. Ferrannini, J. Halcox, W. Kiowski, T. Lüscher, G. Mancia, A. Natali and 8 more. Journal of Hypertension, 2005

768 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/4769379b29ba347779fded105cda4def248435f5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Ralph DeFronzo
2. Rhian M. Touyz
3. I. Tabas
4. K. Bornfeldt

Citations in the corpus

• 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. (2024, positive): “13,14 Endothelial dysfunction is characterized by reduced nitric oxide (NO) availability due to an altered balance between production and degradation.”
• Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 (2010, background): “Nitric oxide deficiency activates multiple pathways involved in atherogenesis [89, 90].”